Insider Transactions in Q4 2020 at Atea Pharmaceuticals, Inc. (AVIR)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 03
2020
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
6,411,355
+50.0%
|
-
|
|
Nov 03
2020
|
Rock Springs Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+7.62%
|
$6,000,000
$24.0 P/Share
|
|
Nov 03
2020
|
Rock Springs Capital Management LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,694,419
+50.0%
|
-
|
|
Nov 03
2020
|
John Vavricka Chief Commercial Officer |
BUY
Conversion of derivative security
|
Indirect |
82,508
+50.0%
|
-
|
|
Nov 03
2020
|
Chung K. Chu > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
176,862
+13.06%
|
-
|
|
Nov 03
2020
|
Jean Pierre Sommadossi President, CEO, and Chairman |
BUY
Conversion of derivative security
|
Indirect |
750,000
+11.24%
|
-
|
|
Nov 03
2020
|
Andrea Corcoran |
BUY
Conversion of derivative security
|
Direct |
133,004
+17.36%
|
-
|
|
Nov 03
2020
|
Franklin M Berger |
BUY
Open market or private purchase
|
Direct |
41,666
+4.84%
|
$999,984
$24.0 P/Share
|
|
Nov 03
2020
|
Franklin M Berger |
BUY
Conversion of derivative security
|
Direct |
759,606
+49.39%
|
-
|
|
Nov 03
2020
|
Polly A. Murphy |
BUY
Conversion of derivative security
|
Indirect |
11,295
+50.0%
|
-
|
|
Nov 03
2020
|
Andrew A. F. Hack Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+4.26%
|
$6,000,000
$24.0 P/Share
|
|
Nov 03
2020
|
Andrew A. F. Hack Director |
BUY
Conversion of derivative security
|
Indirect |
5,365,659
+50.0%
|
-
|